Search Results - "Mujica Mota, Ruben E"

Safety and Effectiveness of Statins for Prevention of Recurrent Myocardial Infarction in 12 156 Typical Older Patients: A Quasi-Experimental Study by Ble, Alessandro, Hughes, Peter M, Delgado, Joao, Masoli, Jane A, Bowman, Kirsty, Zirk-Sadowski, Jan, Mujica Mota, Ruben E, Henley, William E, Melzer, David

“…There is limited evidence on statin risk and effectiveness for patients aged 80+. We estimated risk of recurrent myocardial infarction, muscle-related and…”
Get full text

Azacitidine for Treating Acute Myeloid Leukaemia with More Than 30 % Bone Marrow Blasts: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal by Tikhonova, Irina A., Hoyle, Martin W., Snowsill, Tristan M., Cooper, Chris, Varley-Campbell, Joanna L., Rudin, Claudius E., Mujica Mota, Ruben E.

“…The National Institute for Health and Care Excellence (NICE) invited the manufacturer of azacitidine (Celgene) to submit evidence for the clinical and cost…”
Get full text

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe by Medina Lara, Antonieta, Kigozi, Jesse, Amurwon, Jovita, Muchabaiwa, Lazarus, Nyanzi Wakaholi, Barbara, Mujica Mota, Ruben E, Walker, A Sarah, Kasirye, Ronnie, Ssali, Francis, Reid, Andrew, Grosskurth, Heiner, Babiker, Abdel G, Kityo, Cissy, Katabira, Elly, Munderi, Paula, Mugyenyi, Peter, Hakim, James, Darbyshire, Janet, Gibb, Diana M, Gilks, Charles F

“…Despite funding constraints for treatment programmes in Africa, the costs and economic consequences of routine laboratory monitoring for efficacy and toxicity…”
Get full text

Health Seeking Behavior after Fever Onset in a Malaria-Endemic Area of Malawi by Mota, Ruben E. Mujica, Lara, Antonieta Medina, Kunkwenzu, Esthery D, Lalloo, David G

“…Informal sources of care may lead to ineffective use of antimalarial drugs. A survey conducted in Malawi estimated the frequency of use of informal and formal…”
Get full text

Immunosuppressive agents in adult kidney transplantation in the National Health Service: a model-based economic evaluation by Snowsill, Tristan M, Moore, Jason, Mujica Mota, Ruben E, Peters, Jaime L, Jones-Hughes, Tracey L, Huxley, Nicola J, Coelho, Helen F, Haasova, Marcela, Cooper, Chris, Lowe, Jenny A, Varley-Campbell, Jo L, Crathorne, Louise, Allwood, Matt J, Anderson, Rob

“…Immunosuppression is required in kidney transplantation to prevent rejection and prolong graft survival. We conducted an economic evaluation to support…”
Get full text

Cost-effectiveness of timely versus delayed primary total hip replacement in Germany: A social health insurance perspective by Mujica-Mota, Ruben E, Watson, Leala K, Tarricone, Rosanna, Jäger, Marcus

“…Without clinical guideline on the optimal timing for primary total hip replacement (THR), patients often receive the operation with delay. Delaying THR may…”
Get full text

Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature Review by Ward, Thomas, Mujica-Mota, Ruben E., Spencer, Anne E., Medina-Lara, Antonieta

“…Objective The aim of this study was to review analytical methods that enable the incorporation of equity concerns within economic evaluation. Methods A…”
Get full text

Accounting for Heterogeneity in Resource Allocation Decisions: Methods and Practice in UK Cancer Technology Appraisals by Ward, Thomas, Medina-Lara, Antonieta, Mujica-Mota, Ruben E., Spencer, Anne E.

“…The availability of novel, more efficacious and expensive cancer therapies is increasing, resulting in significant treatment effect heterogeneity and…”
Get full text

Determinants of demand for total hip and knee arthroplasty: a systematic literature review by Mota, Rubén E Mújica, Tarricone, Rosanna, Ciani, Oriana, Bridges, John F P, Drummond, Mike

“…Documented age, gender, race and socio-economic disparities in total joint arthroplasty (TJA), suggest that those who need the surgery may not receive it, and…”
Get full text

Do time trade-off values fully capture attitudes that are relevant to health-related choices? by Spencer, Anne, Tomeny, Ewan, Mujica-Mota, Ruben E., Robinson, Angela, Covey, Judith, Pinto-Prades, Jose Luis

“…Previous research has shown that demographics, beliefs, and self-reported own health influence TTO values. Our hypothesis is that attitudes towards length and…”
Get full text

The heterogeneous causal effects of neonatal care: a model of endogenous demand for multiple treatment options based on geographical access to care by Mújica‐Mota, Rubén E., Landa, Paolo, Pitt, Martin, Allen, Mike, Spencer, Anne

“…Neonatal units in the UK are organised into three levels, from highest Neonatal Intensive Care Unit (NICU), to Local Neonatal Unit (LNU) to lowest Special Care…”
Get full text

Stated preferences for anti-malarial drug characteristics in Zomba, a malaria endemic area of Malawi by Medina-Lara, Antonieta, Mujica-Mota, Ruben E, Kunkwenzu, Esthery D, Lalloo, David G

“…The evidence on determinants of individuals' choices for anti-malarial drug treatments is scarce. This study sought to measure the strength of preference for…”
Get full text

Economic Evaluation of Bortezomib (VELCADE) for Relapsed and Refractory Multiple Myeloma by Bagust, Adrian, Haycox, Alan R., Boland, Angela, Chu, Patrick, Morgan, Gareth J., Mujica Mota, Ruben E., Dubois, Dominique, Dhawan, Ravinder

“…Bortezomib (VELCADE), a new proteasome inhibitor, was recently licensed by the FDA for treating patients with relapsed and refractory multiple myeloma (MM),…”
Get full text